Announcements Trials
Browse Landscape

Phase

Phase NA 20Phase 3 3Phase 2 3Phase 2/3 1

Status

Completed 2Terminated 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Breast 2

Conditions

Breast Neoplasms 2768Carcinoma, Non-Small-Cell Lung 2267Prostatic Neoplasms 1427Colorectal Neoplasms 1295Neoplasms 1260Multiple Myeloma 1086Lung Neoplasms 1050Neoplasm Metastasis 995Leukemia, Myeloid, Acute 985Lymphoma 900Melanoma 864Pancreatic Neoplasms 819Ovarian Neoplasms 805Carcinoma, Hepatocellular 782Stomach Neoplasms 754Recurrence 753Leukemia 733Lymphoma, Non-Hodgkin 685Leukemia, Lymphocytic, Chronic, B-Cell 665Squamous Cell Carcinoma of Head and Neck 618Lymphoma, Large B-Cell, Diffuse 617Precursor Cell Lymphoblastic Leukemia-Lymphoma 605Head and Neck Neoplasms 599Brain Neoplasms 593Carcinoma, Renal Cell 587Glioblastoma 573Rectal Neoplasms 565Sarcoma 523Myelodysplastic Syndromes 522Lymphoma, Follicular 516

Interventions

liposomal doxorubicin 1Mass Screening 1Atorvastatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2 × Heart Diseases × Clear all
NCT01714271 2023-10-02

Promotora-based Latino Family CVD Risk Reduction

University of California, Los Angeles

Phase 2 Completed
204 enrolled

Heart Diseases, Neoplasms

NCT02674204 2019-05-15

STOP

Cedars-Sinai Medical Center

Phase 2 Terminated
2 enrolled 7 charts
Breast

Breast Neoplasms, Heart Diseases, Cardiotoxicity

NCT00563953 2017-10-12

CAPRICE

SOLTI Breast Cancer Research Group

Phase 2 Completed
50 enrolled
Breast

Breast Neoplasms, Heart Diseases, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡